by oliverseo | May 30, 2018 | Uncategorized
NOVARTIS ENTERS AGREEMENT TO ACQUIRE AVEXIS INC. FOR USD 8.7 BN Novartis announced they will merge with AveXis Inc. for 218 per share or a total of 8.7 billion in cash, this transaction was unanimously approved by Boards of both companies. AveXis has ongoing clinical...
by oliverseo | May 30, 2018 | Uncategorized
JOHNSON & JOHNSON’S DARZALEX AMBITIONS TAKE A HIT WITH SCRAPPED I-O TRIALS J&J partners with Genmab announced that they will stop studies of Darzalex in combination with anti-pd-l1, since it failed to show benefit. This prompted Janssen to discontinue phase...
Recent Comments